Betahistine-d3 Dihydrochloride |
|
| Synonyms: N-(Methyl-d3)-2-pyridineethanamine Dihydrochloride; 2-[2-(Methyl-d3-amino)ethyl]pyridine Dihydrochloride; [2-(2-Pyridyl)ethyl]methyl-d3-amine | |
| Cat. No.: B13021 | CAS No.: 244094-72-2/5579-84-0(unlabelled)/244094-70-0(Free |
| MDL.: | Formula: C8H11D3Cl2N2 |
| F.W.212.13 | Purity: 99% |
| Storage: Hygroscopic, -20°C Freezer, Under Inert Atmosphere | |
|   | |
| Catalog Number: | B13021 | CAS No.: | 244094-72-2/5579-84-0(unlabelled)/244094-70-0(Free | |
| MDL: | Formula: | C8H11D3Cl2N2 | ||
| F.W.: | 212.13 | Purity: | 99% | |
| Package: | Unit: | |||
| Appearance: | Pale-Yellow Solid | M.P.: | 145-157ºC | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Methanol (Slightly), Water (Slightly) | Stability: | ||
| Storage: | Hygroscopic, -20°C Freezer, Under Inert Atmosphere | Category: | Reference Standard | |
| Reference: | Gilligan, P., et al.: J. Med. Chem., 43, 1641 (2000), Keller, P., et al.: Bioorg. Med. Chem., 8, 1213 (2000), Hauger, R., et al.: Pharmacol. Rev., 55, 21 (2003), Han, X., et al.: Bioorg. Med. Chem. Lett., 15, 3870 (2005), | |||
| Application: | Labelled Betahistine, which is most commonly used to treat the symptoms of Ménière's disease and vertigo. Vasodilator. | |||
| Category: | Amines, Heterocycles, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, | |||








